Logo-bi
Bioimpacts. 2025;15: 30129 | Published on: 2024 Jun 19. doi: 10.34172/bi.30129
PMID: 39963561        PMCID: PMC11830129

Systematic Review

The effectiveness of antioxidant agents in delaying progression of diabetic nephropathy: A systematic review of randomized controlled trials

Ika Rahayu 1,2 ORCID, Nur Arfian 3,4 * ORCID, Christina Yeni Kustanti 5,6 ORCID, Mae Sri Hartati Wahyuningsih 4,7 ORCID

Cited by CrossRef: 0


1- Tian Y, Wu X, Gong Z, Liang X, Zhu H, Zhang J, Hu Y, Li B, Xu P, Guo K, Yue H. Ozone Exposure Induces Prediabetic Symptoms Through Hepatic Glycogen Metabolism and Insulin Resistance. Toxics. 2025;13(8):652 [Crossref]
2- Mangarov I, Voynikov Y, Petkova V, Iliev S, Kostadinova I, Marinov L, Nikolova I. Alpha-Lipoic Acid in Diabetic Peripheral Neuropathy: Addressing the Challenges and Complexities Surrounding a 70-Year-Old Compound. CIMB. 2025;47(6):402 [Crossref]
3- Guerrero-Mauvecin J, Villar-Gómez N, Miño-Izquierdo L, Povo-Retana A, Ramos A, Ruiz-Hurtado G, Sanchez-Niño M, Ortiz A, Sanz A. Antioxidant Effects of SGLT2 Inhibitors on Cardiovascular–Kidney–Metabolic (CKM) Syndrome. Antioxidants. 2025;14(6):701 [Crossref]
4- Matsui T, Sotokawauchi A, Nishino Y, Koga Y, Yamagishi S. Apixaban Inhibits Progression of Experimental Diabetic Nephropathy by Blocking Advanced Glycation End Product-Receptor Axis. IJMS. 2025;26(7):3007 [Crossref]

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMedPubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science IndicatorsEmbase; EBSCOhost; CAS: DOAJSHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons